From
Vadvert UK:
Agilent Technologies Inc. (NYSE: A) today announced availability of the industry’s first GC/MS compendium to test for
synthetic cannabinoids, recently declared controlled substances by the U.S. Drug Enforcement Agency. They are most commonly found in “herbal incense” blends.
The compendium available from Agilent at no cost to qualified forensics labs, contains detailed procedures for sample preparation and GC/MS method, plus a searchable mass-spectral library to test for 35 synthetic cannabinoids and their derivatives. The method and library were developed in collaboration with the Criminalistics Division of
NMS Labs, an independent forensic laboratory certified by the American Board of Forensic Toxicology and the American Society of Crime Laboratory Directors.